Detailed information for compound 34103

Basic information

Technical information
  • TDR Targets ID: 34103
  • Name: 1-acetyl-5-fluoro-3-(2-methylbenzoyl)pyrimidi ne-2,4-dione
  • MW: 290.247 | Formula: C14H11FN2O4
  • H donors: 0 H acceptors: 4 LogP: 1.29 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccccc1C(=O)n1c(=O)c(F)cn(c1=O)C(=O)C
  • InChi: 1S/C14H11FN2O4/c1-8-5-3-4-6-10(8)12(19)17-13(20)11(15)7-16(9(2)18)14(17)21/h3-7H,1-2H3
  • InChiKey: DRXHAKVGNKHFMB-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 1-acetyl-5-fluoro-3-[o-tolyl(oxo)methyl]pyrimidine-2,4-dione
  • 1-ethanoyl-5-fluoro-3-(2-methylphenyl)carbonyl-pyrimidine-2,4-dione
  • 1-acetyl-5-fluoro-3-o-toluoyl-pyrimidine-2,4-quinone
  • 1-acetyl-3,2-toluyl-5-fluorouracil
  • atofluding
  • 1-acetyl-5-fluoro-3-[(2-methylphenyl)-oxomethyl]pyrimidine-2,4-dione
  • 1-acetyl-5-fluoro-3-(2-methylbenzoyl)pyrimidine-2,4-quinone
  • 71861-76-2
  • 1-Acetyl-5-fluoro-3-(2-methylbenzoyl)-2,4-(1H,3H)-pyrimidinedione
  • 2,4(1H,3H)-Pyrimidinedione, 1-acetyl-5-fluoro-3-(2-methylbenzoyl)-
  • BRN 5598480
  • N(sub 1)-Acetyl-N(sub 3)-o-toluyl-5-fluorouracil
  • A-OT

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 1.7374 1 1
Leishmania major ecotin, putative 0.0294 0 0.5
Mycobacterium ulcerans lipase/esterase LipN 0.0294 0 0.5
Mycobacterium ulcerans esterase LipW 0.0294 0 0.5
Mycobacterium tuberculosis Probable lipase/esterase LipN 0.0294 0 0.5
Trypanosoma cruzi Isoprenylcysteine alpha-carbonyl methylesterase, putative 0.0294 0 0.5
Schistosoma mansoni hormone-sensitive lipase (S09 family) 1.7374 1 1
Onchocerca volvulus 0.0294 0 0.5
Mycobacterium tuberculosis Probable esterase LipO 0.0294 0 0.5
Mycobacterium tuberculosis Probable acetyl-hydrolase/esterase LipR 0.0294 0 0.5
Trypanosoma brucei Isoprenylcysteine alpha-carbonyl methylesterase, putative 0.0294 0 0.5
Schistosoma mansoni hormone-sensitive lipase (S09 family) 1.7374 1 1
Brugia malayi aryl-acylamidase 0.0294 0 0.5
Mycobacterium ulcerans esterase LipC 0.0294 0 0.5
Mycobacterium ulcerans lipase LipU 0.0294 0 0.5
Mycobacterium ulcerans carboxylesterase LipQ 0.0294 0 0.5
Mycobacterium ulcerans esterase/lipase 0.0294 0 0.5
Treponema pallidum N-acetylphosphinothricin-tripetide-deacetylase 0.0294 0 0.5
Mycobacterium ulcerans lipase LipI 0.0294 0 0.5
Mycobacterium tuberculosis Probable lipase LipH 0.0294 0 0.5
Toxoplasma gondii alpha/beta hydrolase fold domain-containing protein 0.0294 0 0.5
Trichomonas vaginalis Esterase, putative 0.0294 0 0.5
Leishmania major hypothetical protein, conserved 0.0294 0 0.5
Mycobacterium ulcerans esterase LipO 0.0294 0 0.5
Mycobacterium tuberculosis Probable esterase/lipase LipF 0.0294 0 0.5
Mycobacterium ulcerans membrane-bound esterase LipM 0.0294 0 0.5
Mycobacterium tuberculosis Possible esterase LipW 0.0294 0 0.5
Mycobacterium tuberculosis Putative acetyl hydrolase MbtJ 0.0294 0 0.5
Trypanosoma cruzi serine peptidase, Clan SC, Family S9D 0.0294 0 0.5
Mycobacterium tuberculosis Probable non lipolytic carboxylesterase NlhH 0.0294 0 0.5
Mycobacterium tuberculosis Probable carboxylesterase LipQ 0.0294 0 0.5
Mycobacterium ulcerans lipase LipH 0.0294 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0294 0 0.5
Mycobacterium tuberculosis Probable esterase LipM 0.0294 0 0.5
Trypanosoma cruzi Alpha/beta hydrolase domain-containing protein 0.0294 0 0.5
Mycobacterium ulcerans hypothetical protein 0.0294 0 0.5
Mycobacterium ulcerans lipase LipU 0.0294 0 0.5
Mycobacterium ulcerans acetyl hydrolase MbtJ 0.0294 0 0.5
Schistosoma mansoni hormone-sensitive lipase (S09 family) 1.7374 1 1
Trypanosoma cruzi Isoprenylcysteine alpha-carbonyl methylesterase, putative 0.0294 0 0.5
Toxoplasma gondii alpha/beta hydrolase fold domain-containing protein 0.0294 0 0.5
Echinococcus multilocularis hormone sensitive lipase 1.7374 1 1
Mycobacterium tuberculosis Possible lipase LipU 0.0294 0 0.5
Mycobacterium leprae Possible lipase LipU 0.0294 0 0.5
Mycobacterium tuberculosis Probable esterase LipC 0.0294 0 0.5
Trichomonas vaginalis Esterase, putative 0.0294 0 0.5
Trichomonas vaginalis Esterase, putative 0.0294 0 0.5

Activities

Activity type Activity value Assay description Source Reference
T/C (functional) = 25 % Antitumor activity against MH 134 cells in female BDF1 mice expressed as percent T/C at dose 200 mg/kg ChEMBL. 7452684
T/C (functional) = 25 % Antitumor activity against MH 134 cells in female BDF1 mice expressed as percent T/C at dose 200 mg/kg ChEMBL. 7452684
T/C (functional) = 32 % Antitumor activity against Meth A cells in female BDF1 mice expressed as percent T/C at dose 200 mg/kg ChEMBL. 7452684
T/C (functional) = 32 % Antitumor activity against Meth A cells in female BDF1 mice expressed as percent T/C at dose 200 mg/kg ChEMBL. 7452684
T/C (functional) = 43 % Antitumor activity against MH 134 cells in female BDF1 mice expressed as percent T/C at dose 100 mg/kg ChEMBL. 7452684
T/C (functional) = 43 % Antitumor activity against MH 134 cells in female BDF1 mice expressed as percent T/C at dose 100 mg/kg ChEMBL. 7452684
T/C (functional) = 58 % Antitumor activity against Meth A cells in female BDF1 mice expressed as percent T/C at dose 100 mg/kg ChEMBL. 7452684
T/C (functional) = 58 % Antitumor activity against Meth A cells in female BDF1 mice expressed as percent T/C at dose 100 mg/kg ChEMBL. 7452684
T/C (functional) = 61 % Antitumor activity against MH 134 cells in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 61 % Antitumor activity against MH 134 cells in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 71 % Antitumor activity against Meth A cells in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 71 % Antitumor activity against Meth A cells in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 110 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 110 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 111 % Antitumor activity against P-388 Leukemia in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 111 % Antitumor activity against P-388 Leukemia in female BDF1 mice expressed as percent T/C at dose 50 mg/kg ChEMBL. 7452684
T/C (functional) = 121 % Percentage change in median survival time of P388 (leukaemia) inoculated female mice following 200 mg/kg i.p. ChEMBL. 7452684
T/C (functional) = 121 % Percentage change in median survival time of P388 (leukaemia) inoculated female mice following 25 mg/kg i.p. ChEMBL. 7452684
T/C (functional) = 121 % Percentage change in median survival time of P388 (leukaemia) inoculated female mice following 200 mg/kg i.p. ChEMBL. 7452684
T/C (functional) = 121 % Percentage change in median survival time of P388 (leukaemia) inoculated female mice following 25 mg/kg i.p. ChEMBL. 7452684
T/C (functional) = 128 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 100 mg/kg ChEMBL. 7452684
T/C (functional) = 128 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 100 mg/kg ChEMBL. 7452684
T/C (functional) = 136 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 200 mg/kg ChEMBL. 7452684
T/C (functional) = 136 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 200 mg/kg ChEMBL. 7452684
T/C (functional) = 151 % Percentage change in median survival time of P388 (leukaemia) inoculated female mice following 100 mg/kg i.p. ChEMBL. 7452684
T/C (functional) = 151 % Percentage change in median survival time of P388 (leukaemia) inoculated female mice following 100 mg/kg i.p. ChEMBL. 7452684
T/C (functional) = 167 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 300 mg/kg ChEMBL. 7452684
T/C (functional) = 167 % Antitumor activity against L-1210 cells in female BDF1 mice expressed as percent T/C at dose 300 mg/kg ChEMBL. 7452684

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.